Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
DORZOLAMIDA ARENA 20 mg
Ophthalmic drug (carbonic anhydrase inhibitor), indicated in the treatment of glaucoma
Active Substance (INN)
DORZOLAMIDUM
Packaging
box x 1 bottle
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.